Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Nov;119(5):905–910. doi: 10.1111/j.1476-5381.1996.tb15758.x

Somatostatin sst2 receptor-mediated inhibition of parietal cell function in rat isolated gastric mucosa.

M A Wyatt 1, E Jarvie 1, W Feniuk 1, P P Humphrey 1
PMCID: PMC1915956  PMID: 8922739

Abstract

1. The aim of this study was to determine the location and functional characteristics of the somatostatin (SRIF) receptor type(s) which mediate inhibition of acid secretion in rat isolated gastric mucosa. 2. Gastrin (1 nM-1 microM), dimaprit (10 microM-300 microM) and isobutyl methylxanthine (IBMX, 1 microM-100 microM) all caused concentration-dependent increases in acid output. Responses to gastrin were almost completely inhibited by ranitidine (10 microM) at a concentration which abolished the secretory response to dimaprit. In contrast, responses to IBMX were not changed by ranitidine suggesting that IBMX acts directly on the parietal cell and not indirectly by releasing histamine from enterochromaffin-like (ECL) cells. 3. SRIF-14 (1 nM-1 microM) had no effect on basal acid output, but inhibited acid output produced by gastrin, dimaprit and IBMX in a concentration-dependent manner with respective EC50 values of 46, 54 and 167 nM. The peptidase inhibitors, amastatin (10 microM) and phosphoramidon (1 microM), had no effect on SRIF-induced inhibition of dimaprit stimulated gastric acid secretion. 4. The inhibitory effect of a range of SRIF analogues on gastrin-, dimaprit- and IBMX-induced acid secretion was also studied. Irrespective of the secretagogue used to increase acid output, the rank order of potencies was similar (BIM-23027 = seglitide = octreotide > SRIF-14 = SRIF-28 > L-362,855). The linear peptide BIM-23056 was devoid of agonist or antagonist activity in concentrations up to 1 microM. 5. The sst2 receptor selective peptides, BIM-23027, seglitide and octreotide were the most potent inhibitors of gastrin-, dimaprit- and IBMX-induced acid secretion suggesting that SRIF receptors resembling the recombinant sst2 receptors are involved. Furthermore, since dimaprit and IBMX stimulate gastric acid secretion independently of histamine release, sst2 receptor-mediated inhibition must occur at the level of the parietal cell itself.

Full text

PDF
905

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arimura A., Sato H., Dupont A., Nishi N., Schally A. V. Somatostatin: abundance of immunoreactive hormone in rat stomach and pancreas. Science. 1975 Sep 19;189(4207):1007–1009. doi: 10.1126/science.56779. [DOI] [PubMed] [Google Scholar]
  2. Bruno J. F., Xu Y., Song J., Berelowitz M. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology. 1993 Dec;133(6):2561–2567. doi: 10.1210/endo.133.6.8243278. [DOI] [PubMed] [Google Scholar]
  3. Feniuk W., Dimech J., Humphrey P. P. Characterization of somatostatin receptors in guinea-pig isolated ileum, vas deferens and right atrium. Br J Pharmacol. 1993 Nov;110(3):1156–1164. doi: 10.1111/j.1476-5381.1993.tb13935.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hoyer D., Bell G. I., Berelowitz M., Epelbaum J., Feniuk W., Humphrey P. P., O'Carroll A. M., Patel Y. C., Schonbrunn A., Taylor J. E. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci. 1995 Mar;16(3):86–88. doi: 10.1016/s0165-6147(00)88988-9. [DOI] [PubMed] [Google Scholar]
  5. Hoyer D., Lübbert H., Bruns C. Molecular pharmacology of somatostatin receptors. Naunyn Schmiedebergs Arch Pharmacol. 1994 Nov;350(5):441–453. doi: 10.1007/BF00173012. [DOI] [PubMed] [Google Scholar]
  6. Kurokawa M., Kirk I. P., Kirkpatrick K. A., Kase H., Richardson P. J. Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release. Br J Pharmacol. 1994 Sep;113(1):43–48. doi: 10.1111/j.1476-5381.1994.tb16171.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Le Romancer M., Cherifi Y., Levasseur S., Laigneau J. P., Peranzi G., Jais P., Lewin M. J., Reyl-Desmars F. Messenger RNA expression of somatostatin receptor subtypes in human and rat gastric mucosae. Life Sci. 1996;58(13):1091–1098. doi: 10.1016/0024-3205(96)00063-x. [DOI] [PubMed] [Google Scholar]
  8. Lloyd K. C., Wang J., Aurang K., Grönhed P., Coy D. H., Walsh J. H. Activation of somatostatin receptor subtype 2 inhibits acid secretion in rats. Am J Physiol. 1995 Jan;268(1 Pt 1):G102–G106. doi: 10.1152/ajpgi.1995.268.1.G102. [DOI] [PubMed] [Google Scholar]
  9. McKeen E. S., Feniuk W., Humphrey P. P. Mediation by SRIF1 receptors of the contractile action of somatostatin in rat isolated distal colon; studies using some novel SRIF analogues. Br J Pharmacol. 1994 Oct;113(2):628–634. doi: 10.1111/j.1476-5381.1994.tb17036.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McKeen E. S., Feniuk W., Humphrey P. P. Somatostatin receptors mediating inhibition of basal and stimulated electrogenic ion transport in rat isolated distal colonic mucosa. Naunyn Schmiedebergs Arch Pharmacol. 1995 Oct;352(4):402–411. doi: 10.1007/BF00172777. [DOI] [PubMed] [Google Scholar]
  11. Park J., Chiba T., Yamada T. Mechanisms for direct inhibition of canine gastric parietal cells by somatostatin. J Biol Chem. 1987 Oct 15;262(29):14190–14196. [PubMed] [Google Scholar]
  12. Patel Y. C., Srikant C. B. Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology. 1994 Dec;135(6):2814–2817. doi: 10.1210/endo.135.6.7988476. [DOI] [PubMed] [Google Scholar]
  13. Payne N. A., Gerber J. G. Differential effects of somatostatin and prostaglandins on gastric histamine release to pentagastrin. J Pharmacol Exp Ther. 1992 Nov;263(2):520–526. [PubMed] [Google Scholar]
  14. Penman E., Wass J. A., Butler M. G., Penny E. S., Price J., Wu P., Rees L. H. Distribution and characterisation of immunoreactive somatostatin in human gastrointestinal tract. Regul Pept. 1983 Sep;7(1):53–65. doi: 10.1016/0167-0115(83)90281-1. [DOI] [PubMed] [Google Scholar]
  15. Prinz C., Sachs G., Walsh J. H., Coy D. H., Wu S. V. The somatostatin receptor subtype on rat enterochromaffinlike cells. Gastroenterology. 1994 Oct;107(4):1067–1074. doi: 10.1016/0016-5085(94)90231-3. [DOI] [PubMed] [Google Scholar]
  16. Raulf F., Pérez J., Hoyer D., Bruns C. Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue. Digestion. 1994;55 (Suppl 3):46–53. doi: 10.1159/000201201. [DOI] [PubMed] [Google Scholar]
  17. Raynor K., Murphy W. A., Coy D. H., Taylor J. E., Moreau J. P., Yasuda K., Bell G. I., Reisine T. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Mol Pharmacol. 1993 Jun;43(6):838–844. [PubMed] [Google Scholar]
  18. Reeves J. J., Stables R. Effects of indomethacin, piroxicam and selected prostanoids on gastric acid secretion by the rat isolated gastric mucosa. Br J Pharmacol. 1985 Nov;86(3):677–684. doi: 10.1111/j.1476-5381.1985.tb08945.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rossowski W. J., Gu Z. F., Akarca U. S., Jensen R. T., Coy D. H. Characterization of somatostatin receptor subtypes controlling rat gastric acid and pancreatic amylase release. Peptides. 1994;15(8):1421–1424. doi: 10.1016/0196-9781(94)90118-x. [DOI] [PubMed] [Google Scholar]
  20. Ruggere M. D., Patel Y. C. Somatostatin metabolism by the isolated rat lung. Endocrinology. 1985 Nov;117(5):1870–1873. doi: 10.1210/endo-117-5-1870. [DOI] [PubMed] [Google Scholar]
  21. Schmidtler J., Rosenthal W., Offermanns S., Schusdziarra V., Classen M., Schepp W. Pertussis toxin reverses prostaglandin E2- and somatostatin-induced inhibition of rat parietal cell H(+)-production. Cell Signal. 1992 May;4(3):321–329. doi: 10.1016/0898-6568(92)90072-g. [DOI] [PubMed] [Google Scholar]
  22. Taborsky G. J., Jr, Ensinck J. W. Extraction of somatostatin by the pancreas. Endocrinology. 1983 Jan;112(1):303–307. doi: 10.1210/endo-112-1-303. [DOI] [PubMed] [Google Scholar]
  23. Tanaka T., Tani S. Inhibitory action of somatostatin on cAMP dependent pepsinogen secretion from rat gastric chief cells: involvement of pertussis toxin-sensitive G-protein. Biol Pharm Bull. 1994 Mar;17(3):415–418. doi: 10.1248/bpb.17.415. [DOI] [PubMed] [Google Scholar]
  24. Vanetti M., Kouba M., Wang X., Vogt G., Höllt V. Cloning and expression of a novel mouse somatostatin receptor (SSTR2B). FEBS Lett. 1992 Oct 26;311(3):290–294. doi: 10.1016/0014-5793(92)81122-3. [DOI] [PubMed] [Google Scholar]
  25. Welsh N. J., Shankley N. P., Black J. W. Comparative study of the control of basal acid output from rodent isolated stomachs. Br J Pharmacol. 1993 Aug;109(4):941–945. doi: 10.1111/j.1476-5381.1993.tb13711.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Wilkinson G. F., Thurlow R. J., Sellers L. A., Coote J. E., Feniuk W., Humphrey P. P. Potent antagonism by BIM-23056 at the human recombinant somatostatin sst5 receptor. Br J Pharmacol. 1996 Jun;118(3):445–447. doi: 10.1111/j.1476-5381.1996.tb15423.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES